Cargando…
MEDB-54. Standard Risk Medulloblastoma treated solely with surgery and chemo-radiation
INTRODUCTION: Medulloblastoma is the most common malignant brain tumor in children, with 5-year overall survival (OS) ranging from 60%-95% depending on subgroup and risk status. The POG 8631/CCG 923 trial (accrual 1986-1990) found a 63% 5 year OS for patients with local disease after gross total res...
Autores principales: | Cantor, Evan, Meyer, Ashley, Ogle, Andrea, McHugh, Michele, Beck, Mary, Green, Tammy, Ramachandran, Lakshmi, Dahiya, Sonika, Cluster, Andrew, Brossier, Nicole M, Abdelbaki, Mohamed S, Limbrick, David, Perkins, Stephanie, Shatara, Margaret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165320/ http://dx.doi.org/10.1093/neuonc/noac079.428 |
Ejemplares similares
-
MEDB-33. The landscape of ecDNA in medulloblastoma
por: Chapman, Owen, et al.
Publicado: (2022) -
MEDB-31. THE CLINICAL SIGNIFICANCE OF EXTENT OF RESECTION IN MEDULLOBLASTOMA
por: Keeling, Claire, et al.
Publicado: (2022) -
MEDB-44. Transcriptomic resolution of subgroup-specific medulloblastoma architecture
por: Willard, Nicholas, et al.
Publicado: (2022) -
MEDB-72. MOLECULAR CHARACTERIZATION OF MEDULLOBLASTOMAS IN A SINGLE INSTITUTION
por: Tan, Enrica E K, et al.
Publicado: (2022) -
MEDB-23. Targeting epigenetic dysregulation in medulloblastoma with poor prognosis
por: Badodi, Sara, et al.
Publicado: (2022)